Gene · 4591
Papers1,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Autoimmune Haemolytic Anaemia Due to Cold Antibodies in a Renal Cancer Patient. | Case Rep Oncol | 2022 | 35702677 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Protocol for high-throughput cloning, expression, purification, and evaluation of bispecific antibodies. | STAR Protoc | 2022 | 35664258 | PubTator, text mining | PubMed |
| Condensates induced by transcription inhibition localize active chromatin to nucleoli. | Mol Cell | 2022 | 35662392 | PubTator, text mining | PubMed |
| Stoichiometry-Selective Antagonism of α4β2 Nicotinic Acetylcholine Receptors by Fluoroquinolone Antibiotics. | ACS Chem Neurosci | 2022 | 35657695 | PubTator, text mining | PubMed |
| A nationwide longitudinal study on risk factors for progression of anal intraepithelial neoplasia grade 3 to anal cancer. | Int J Cancer | 2022 | 35657350 | PubTator, text mining | PubMed |
| Stability Analysis and Optimal Control Strategies of an Echinococcosis Transmission Model. | Comput Math Methods Med | 2022 | 35651923 | PubTator, text mining | PubMed |
| A Combination of Cytokine-Induced Killer Cells With PD-1 Blockade and ALK Inhibitor Showed Substantial Intrinsic Variability Across Non-Small Cell Lung Cancer Cell Lines. | Front Oncol | 2022 | 35646685 | PubTator, text mining | PubMed |
| Hematological Findings in Lysosomal Storage Disorders: A Perspective from the Medical Laboratory. | EJIFCC | 2022 | 35645695 | PubTator, text mining | PubMed |
| Predicting progression to severe COVID-19 using the PAINT score. | BMC Infect Dis | 2022 | 35619076 | PubTator, text mining | PubMed |
| Retraction notice to " LncRNA NEAT1 acts as a key regulator of cell apoptosis and inflammatory response by the miR-944/TRIM37 axis in acute lung injury'" [J. Pharmacol. Sci. 145 (2021) 202-212]. | J Pharmacol Sci | 2022 | 35618617 | PubTator, text mining | PubMed |
| Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 study. | Cell Rep Med | 2022 | 35617957 | PubTator, text mining | PubMed |
| Genetic spectrum of prenatally diagnosed skeletal dysplasias in a Finnish patient cohort. | Prenat Diagn | 2022 | 35611473 | PubTator, text mining | PubMed |
| Proteolysis in Reproduction: Lessons From Gene-Modified Organism Studies. | Front Endocrinol (Lausanne) | 2022 | 35600599 | PubTator, text mining | PubMed |
| Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder. | Intern Med | 2022 | 35598995 | PubTator, text mining | PubMed |
| Killing Two Birds With One Stone: Effective Control of Both Non-Small Cell Lung Cancer and Progressive Multifocal Leukoencephalopathy With Atezolizumab, A Case Report. | Front Immunol | 2022 | 35592313 | PubTator, text mining | PubMed |
| HBV pgRNA profiles in Chinese HIV/HBV coinfected patients under pre- and posttreatment: a multicentre observational cohort study. | J Viral Hepat | 2022 | 35582838 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of novel pyrazolo [3,4-d]pyrimidine derivatives as potent PLK4 inhibitors for the treatment of TRIM37-amplified breast cancer. | Eur J Med Chem | 2022 | 35576702 | PubTator, text mining | PubMed |
| Dissecting the Functional Role of the TRIM8 Protein on Cancer Pathogenesis. | Cancers (Basel) | 2022 | 35565438 | PubTator, text mining | PubMed |
| Cullin 3 Exon 9 Deletion in Familial Hyperkalemic Hypertension Impairs Cullin3-Ring-E3 Ligase (CRL3) Dynamic Regulation and Cycling. | Int J Mol Sci | 2022 | 35563538 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4591/papers?page=19